(Stroke. 1995;26:117-122.)
© 1995 American Heart Association, Inc.
Articles |
Cerebroprotective Effect of Lamotrigine After Focal Ischemia in Rats
From the Department of Neurology, Institute of Psychiatry, De Crespigny Park, Denmark Hill, UK.
Correspondence to B.S. Meldrum, Department of Neurology, Institute of Psychiatry, De Crespigny Park, Denmark Hill, SE5 8AF, UK.
Background and Purpose Glutamate receptor antagonists are protective in animal models of focal cerebral ischemia. Lamotrigine (3,5-diamino-6-[2,3-dichlorophenyl]-1,2,4-triazine) is an anticonvulsant drug that blocks voltage-gated sodium channels and inhibits the ischemia-induced release of glutamate. We describe the cerebroprotective effect of lamotrigine (as the isethionate salt) after middle cerebral artery occlusion in rats.
Methods Neurological deficit and infarct volume (visualized by the lack of reduction of 2,3,5-triphenyltetrazolium chloride) 24 hours after permanent left middle cerebral artery occlusion were studied in Fischer rats (n=8 per group per dose).
Results Lamotrigine at 20 mg/kg IV over 10 minutes administered immediately after middle cerebral artery occlusion reduced total infarct volume by 31% and cortical infarct volume by 52%. Lamotrigine at 8 mg/kg IV over 10 minutes reduced cortical infarct volume by 38%. Lamotrigine at 50 mg/kg IV for 10 minutes was not cerebroprotective and induced a decrease of 29±15 mm Hg in mean arterial blood pressure (P<.05, n=8). The optimum dose of lamotrigine (20 mg/kg IV over 10 minutes) when administered with a 1-hour delay after middle cerebral artery occlusion reduced cortical infarct volume by 41%. Lamotrigine (20 mg/kg IV over 10 minutes) with a 2-hour delay after middle cerebral artery occlusion was ineffective. Neurological deficits after 24 hours were improved after immediate treatment with lamotrigine at 20 mg/kg IV over 10 minutes.
Conclusions The cerebroprotective effect of lamotrigine in rats is limited to a narrow dose range between 8 and 20 mg/kg. Lamotrigine or analogous compounds may be useful when given shortly after the onset of stroke.
Key Words: cerebral ischemia • sodium channels • neuroprotection • glutamates • rats
This article has been cited by other articles:
 |
|
 |
|
  R. M. Pressler, C. D. Binnie, S. G. Coleshill, G. A. Chorley, and R. O. Robinson Effect of lamotrigine on cognition in children with epilepsy Neurology, May 23, 2006; 66(10): 1495 - 1499. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Calabresi, B. Picconi, E. Saulle, D. Centonze, A. H. Hainsworth, G. Bernardi, and G. Z. Feuerstein Is Pharmacological Neuroprotection Dependent on Reduced Glutamate Release? • Editorial Comment Stroke, March 1, 2000; 31(3): 766 - 773. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. K. Callaway, M. J. Knight, D. J. Watkins, P. M. Beart, B. Jarrott, and J. A. Clemens Delayed Treatment With AM-36, a Novel Neuroprotective Agent, Reduces Neuronal Damage After Endothelin-1-Induced Middle Cerebral Artery Occlusion in Conscious Rats • Editorial Comment Stroke, December 1, 1999; 30(12): 2704 - 2712. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Lipton Ischemic Cell Death in Brain Neurons Physiol Rev, October 1, 1999; 79(4): 1431 - 1568. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. C. Crumrine, K. Bergstrand, A. T. Cooper, W. L. Faison, and B. R. Cooper Lamotrigine Protects Hippocampal CA1 Neurons From Ischemic Damage After Cardiac Arrest Stroke, November 1, 1997; 28(11): 2230 - 2237. [Abstract] [Full Text]
|
|
|
|
|
|
K. M. Cockroft, M. Meistrell III, G. A. Zimmerman, D. Risucci, O. Bloom, A. Cerami, K. J. Tracey, and G. Feuerstein Cerebroprotective Effects of Aminoguanidine in a Rodent Model of Stroke Stroke, August 1, 1996; 27(8): 1393 - 1398. [Abstract] [Full Text]
|
|